Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine citrate disodium oral solution in Chinese pediatric allergic rhinitis
CTR20213058Phase 2Completed
- Sponsor
- Hefei Enrite Pharmaceutical
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of desloratadine in allergic rhinitis (AR), urticaria, sponsored by Hefei Enrite Pharmaceutical. Started Dec 2021; status: completed.
02
Drugs
desloratadine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on CTR20213058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213058.